BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 25658534)

  • 21. The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan.
    Asai N; Sakanashi D; Suematsu H; Kato H; Hagihara M; Nishiyama N; Koizumi Y; Yamagishi Y; Mikamo H
    J Infect Chemother; 2018 Jul; 24(7):505-509. PubMed ID: 29548627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies.
    Satlin MJ; Cohen N; Ma KC; Gedrimaite Z; Soave R; Askin G; Chen L; Kreiswirth BN; Walsh TJ; Seo SK
    J Infect; 2016 Oct; 73(4):336-45. PubMed ID: 27404978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection.
    Ben-David D; Maor Y; Keller N; Regev-Yochay G; Tal I; Shachar D; Zlotkin A; Smollan G; Rahav G
    Infect Control Hosp Epidemiol; 2010 Jun; 31(6):620-6. PubMed ID: 20370465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association between infection control interventions and carbapenem-resistant Enterobacteriaceae incidence in an endemic hospital.
    Hussein K; Rabino G; Eluk O; Warman S; Reisner S; Geffen Y; Halif L; Paul M
    J Hosp Infect; 2017 Nov; 97(3):218-225. PubMed ID: 28743504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Factors for Recurrence of Carbapenem-Resistant Enterobacteriaceae Carriage: Case-Control Study.
    Bart Y; Paul M; Eluk O; Geffen Y; Rabino G; Hussein K
    Infect Control Hosp Epidemiol; 2015 Aug; 36(8):936-41. PubMed ID: 25869912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proactive infection control measures to prevent nosocomial transmission of carbapenem-resistant Enterobacteriaceae in a non-endemic area.
    Cheng VC; Chan JF; Wong SC; Chen JH; Tai JW; Yan MK; Kwan GS; Tse H; To KK; Ho PL; Yuen KY
    Chin Med J (Engl); 2013 Dec; 126(23):4504-9. PubMed ID: 24286415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbapenem-resistant
    Ruvinsky S; Voto C; Roel M; Deschutter V; Ferraro D; Aquino N; Reijtman V; Galvan ME; Motto E; García M; Sarkis C; Bologna R
    Front Public Health; 2022; 10():983174. PubMed ID: 36091556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013.
    Guh AY; Bulens SN; Mu Y; Jacob JT; Reno J; Scott J; Wilson LE; Vaeth E; Lynfield R; Shaw KM; Vagnone PM; Bamberg WM; Janelle SJ; Dumyati G; Concannon C; Beldavs Z; Cunningham M; Cassidy PM; Phipps EC; Kenslow N; Travis T; Lonsway D; Rasheed JK; Limbago BM; Kallen AJ
    JAMA; 2015 Oct; 314(14):1479-87. PubMed ID: 26436831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities.
    Bhargava A; Hayakawa K; Silverman E; Haider S; Alluri KC; Datla S; Diviti S; Kuchipudi V; Muppavarapu KS; Lephart PR; Marchaim D; Kaye KS
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):398-405. PubMed ID: 24602945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of active surveillance and infection control measures on carbapenem-resistant Gram-negative bacterial colonization and infections in intensive care.
    Karampatakis T; Tsergouli K; Iosifidis E; Antachopoulos C; Karapanagiotou A; Karyoti A; Gritsi-Gerogianni N; Tsakris A; Roilides E
    J Hosp Infect; 2018 Aug; 99(4):396-404. PubMed ID: 29792971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deconstructing the infection control bundles for the containment of carbapenem-resistant Enterobacteriaceae.
    Munoz-Price LS; Quinn JP
    Curr Opin Infect Dis; 2013 Aug; 26(4):378-87. PubMed ID: 23806900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-surgical mediastinitis due to carbapenem-resistant Enterobacteriaceae: Clinical, epidemiological and survival characteristics.
    Abboud CS; Monteiro J; Stryjewski ME; Zandonadi EC; Barbosa V; Dantas D; Sousa EE; Fonseca MJ; Jacobs DM; Pignatari AC; Kiffer C; Rao GG
    Int J Antimicrob Agents; 2016 May; 47(5):386-90. PubMed ID: 27155944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active surveillance for carbapenem resistant enterobacteriaceae (CRE) using stool cultures as a method to decrease CRE infections in the pediatric intensive care unit (PICU).
    Krupanandan RK; Kapalavai SK; Ekka AS; Balusamy I; Sadasivam K; Nambi P S; Ramachandran B
    Indian J Med Microbiol; 2023; 44():100370. PubMed ID: 37356850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statewide surveillance of carbapenem-resistant enterobacteriaceae in Michigan.
    Brennan BM; Coyle JR; Marchaim D; Pogue JM; Boehme M; Finks J; Malani AN; VerLee KE; Buckley BO; Mollon N; Sundin DR; Washer LL; Kaye KS
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):342-9. PubMed ID: 24602937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
    Goodman KE; Simner PJ; Tamma PD; Milstone AM
    Expert Rev Anti Infect Ther; 2016; 14(1):95-108. PubMed ID: 26535959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of Persistent Carbapenem-Resistant Enterobacteriaceae Carriage upon Readmission and Score Development.
    Ciobotaro P; Flaks-Manov N; Oved M; Schattner A; Hoshen M; Ben-Yosef E; Balicer RD; Zimhony O
    Infect Control Hosp Epidemiol; 2016 Feb; 37(2):188-96. PubMed ID: 26750741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence of carbapenem-resistant Enterobacteriaceae in a UK paediatric hospital.
    Drew RJ; Turton JF; Hill RL; Livermore DM; Woodford N; Paulus S; Cunliffe NA
    J Hosp Infect; 2013 Aug; 84(4):300-4. PubMed ID: 23831281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical epidemiology of carbapenem-resistant enterobacteriaceae in community hospitals: a case-case-control study.
    Lee GC; Lawson KA; Burgess DS
    Ann Pharmacother; 2013 Sep; 47(9):1115-21. PubMed ID: 24259725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbapenem-resistant Enterobacteriaceae and the correlation between carbapenem and fluoroquinolone usage and resistance in the US military health system.
    Lesho EP; Clifford RJ; Chukwuma U; Kwak YI; Maneval M; Neumann C; Xie S; Nielsen LE; Julius MD; McGann P; Waterman PE
    Diagn Microbiol Infect Dis; 2015 Feb; 81(2):119-25. PubMed ID: 25497458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.